Skip to main content

Clifford Chance

Clifford Chance

Briefings

Healthcare & Life Sciences Update: The Netherlands

30 October 2015

The legal landscape for companies active in the Dutch healthcare and life sciences sector is ever-changing. Recent changes include: the broadening of the duty to report serious adverse events in medical research, the amended assessment of non-interventional studies, and the new rules regarding online sales of pharmaceuticals. This edition of our Healthcare & Life Sciences Update highlights some of the latest developments in regulations and enforcement which may impact your business.

Download PDF